V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250010977 | 250008178 | 1.51 | 62 | Palliative (P) | null | 2016-04-09 | Azacitidine | N | N | 250008123 | COMMAND TRIAL |
| 250010978 | 250008179 | null | 108.4 | Palliative (P) | 2013-11-16 | 2013-11-16 | Abiraterone | N | N | 250008267 | GEMCARBO |
| 250010979 | 250008179 | null | 75 | null | 2017-03-18 | 2017-04-13 | Cytarabine Low Dose | 02 | N | 250008267 | LIPOSOMAL DOXORUBICIN |
| 250010980 | 250012807 | null | 89 | Palliative (P) | 2018-12-03 | 2018-12-11 | Carboplatin + Paclitaxel (weekly) | N | N | 250008446 | GEMCITABINE + TREOSULPHAN |
| 250010981 | 250008181 | 1.53 | 86.8 | Disease modification (D) | 2016-03-15 | 2016-08-09 | Brentuximab | N | N | 250008453 | IPM |
| 250010982 | 250008181 | 1.63 | 67.7 | Palliative (P) | 2017-10-09 | 2017-10-11 | Busulfan Oral | N | N | 250008453 | GEMCITABINE |
| 250010983 | 250008184 | 1.77 | 62.1 | null | 2017-04-01 | 2017-05-01 | BUSULFAN | null | N | 250008578 | EOX |
| 250010984 | 250008185 | 1.58 | 0 | Palliative (P) | 2018-08-18 | 2018-12-29 | Carboplatin + Vinorelbine Oral | 02 | N | 250008692 | GEMCARBO |
| 250010985 | 250008185 | 1.72 | 71.1 | Not known (9) | 2016-06-03 | 2016-08-10 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 250008692 | CISPLATIN + VINORELBINE |
| 250010986 | 250008186 | 1.67 | 54 | Palliative (P) | 2017-12-26 | 2017-12-26 | ATG + Busulfan + Fludarabine | 2 | N | 250008903 | RITUXIMAB |
| 250010987 | 250011053 | 1.62 | 96.4 | Palliative (P) | 2014-04-14 | 2014-04-14 | IPM | N | N | 250008903 | VENETOCLAX |
| 250010988 | 250008187 | 1.8 | 73.5 | Palliative (P) | 2017-03-11 | 2017-03-11 | GemCarbo Days 1+8 | 02 | N | 250008992 | IPM |
| 250010989 | 250008188 | 1.52 | 58.3 | Curative (C) | 2016-03-01 | 2016-03-01 | CARBOPLATIN + GEMCITABINE | N | N | 250009071 | DA |
| 250010990 | 250008189 | 1.72 | 95.5 | Palliative (P) | 2013-05-25 | 2013-06-01 | CISPLATIN + Ganetespib + Ganetespib + PEMETREXED | N | N | 250009282 | RADIUM 223 |
| 250010991 | 250008190 | null | null | Neo-adjuvant (N) | 2015-03-17 | 2015-03-22 | Carboplatin + Vinorelbine IV | 02 | N | 250010007 | CYTARABINE |
| 250010992 | 250008190 | 1.7 | 98.7 | Palliative (P) | 2018-04-07 | 2018-04-07 | GEMCITABINE | 02 | Y | 250010007 | GEMCARBO |
| 250010993 | 250008190 | 1.68 | 80.7 | Palliative (P) | 2017-07-22 | 2017-07-22 | CHOP R - 21 days | 2 | N | 250010007 | IPM |
| 250010994 | 250008190 | null | null | Palliative (P) | 2018-11-25 | 2018-11-25 | ETOPOSIDE | N | N | 250010007 | GEMCARBO |
| 250010995 | 250008191 | 178 | 52.6 | Disease modification (D) | 2015-03-01 | 2015-07-12 | Temozolomide 150mg/m2 | N | N | 250010178 | IPM |
| 250010996 | 250008192 | 1.65 | 66.8 | Palliative (P) | 2014-05-13 | 2014-05-18 | PEMBROLIZUMAB | N | null | 250010247 | MITOXANTRONE |
| 250010997 | 250008192 | 1.67 | 50.7 | Palliative (P) | 2013-04-20 | 2013-05-16 | Enzalutamide | 02 | null | 250010247 | CISPLATIN + GEMCITABINE |
| 250010998 | 250008193 | 1.75 | 55.2 | Curative (C) | null | 2018-04-17 | Azacitidine | N | N | 250010404 | CARBOPLATIN |
| 250010999 | 250008193 | 0 | 52.6 | null | 2016-03-04 | 2016-03-06 | DA 3 + 10 | 2 | N | 250010404 | GEMCARBO |
| 250011000 | 250011059 | 1.72 | 93 | Disease modification (D) | 2017-07-29 | 2017-07-29 | EOX | N | N | 250010735 | CARBOPLATIN |
| 250011001 | 250008194 | 1.75 | 92.1 | Palliative (P) | 2018-04-08 | 2018-04-30 | Rituximab | 02 | N | 250010740 | COMMAND TRIAL |
| 250011002 | 250008195 | 1.78 | null | Curative (C) | 2018-07-01 | 2018-07-01 | CYCLOPHOSPHAMIDE + MESNA | N | N | 250010744 | CAPECITABINE |
| 250011003 | 250008196 | 1.6 | 85 | Curative (C) | 2017-06-12 | 2017-06-28 | Eribulin | 02 | N | 250010821 | GEMCARBO |
| 250011004 | 250008197 | 1.53 | 73 | Curative (C) | 2018-06-01 | 2018-07-02 | FEC + DOCETAXEL | 02 | N | 250010823 | AZACITIDINE |
| 250011005 | 250008197 | 1.84 | 57.8 | Palliative (P) | 2018-12-06 | 2018-12-11 | DA 3+8 | 02 | N | 250010823 | IPM |
| 250011006 | 250008197 | null | 49 | Palliative (P) | 2018-12-29 | 2018-12-29 | Busulfan Oral | N | N | 250010823 | LIPOSOMAL DOXORUBICIN |
| 250011007 | 250008197 | 0 | 86 | Disease modification (D) | null | 2017-11-30 | R GCVP | N | N | 250010823 | GEMCARBO |
| 250011008 | 250008198 | 1.61 | 48.5 | Palliative (P) | 2018-10-03 | 2018-10-03 | Carboplatin + Paclitaxel (3 weekly) | null | N | 250011409 | CARBOPLATIN + VINORELBINE |
| 250011009 | 250008200 | 1.73 | 86 | Palliative (P) | 2019-02-08 | 2019-02-08 | PEMBROLIZUMAB | N | N | 250011409 | NOT MATCHED |
| 250011010 | 250012191 | 1.6 | 72 | Palliative (P) | 2018-11-15 | 2018-11-17 | GemCarbo Days 1+8 | N | N | 250011913 | GEMCITABINE |
| 250011011 | 250008202 | null | 100 | Palliative (P) | 2014-05-03 | 2014-05-03 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 250012125 | CARBOPLATIN + VINORELBINE |
| 250011012 | 250008206 | 0 | 86 | Palliative (P) | 2016-09-05 | 2016-09-05 | CTD (Thalidomide 200mg) | Y | N | 250012125 | PEMETREXED |
| 250011013 | 250008206 | 1.64 | 70 | Curative (C) | 2017-11-05 | 2017-11-05 | BUSULFAN | 01 | N | 250012125 | CARBOPLATIN |
| 250011014 | 250008206 | 1.85 | 61.2 | Palliative (P) | 2016-10-29 | 2016-11-01 | BUSULFAN | N | N | 250012125 | CARBOPLATIN + VINORELBINE |
| 250011015 | 250008206 | 1.73 | 75.2 | Disease modification (D) | 2016-07-07 | 2016-07-16 | GemCarbo Days 1+8 | 02 | N | 250012125 | EPIRUBICIN |
| 250011016 | 250008207 | 1.63 | 92.1 | Palliative (P) | 2018-03-29 | 2018-03-29 | Carboplatin AUC 6 - 10 | 02 | N | 250013214 | AZACITIDINE |
| 250011017 | 250008209 | 1.51 | 79.3 | Disease modification (D) | 2016-02-26 | 2017-01-06 | Paclitaxel 7 day | N | N | 250013493 | PEMETREXED |
| 250011018 | 250008210 | null | 76.8 | Palliative (P) | 2017-01-04 | 2017-01-04 | AML18 PILOT TRIAL | N | N | 250013495 | COMMAND TRIAL |
| 250011019 | 250008211 | 1.64 | 51.8 | Palliative (P) | 2015-04-14 | 2015-04-21 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 250013643 | GEMCARBO |
| 250011020 | 250008212 | null | 101 | Curative (C) | 2016-08-05 | 2016-08-05 | CISPLATIN + VINORELBINE | N | N | 250013836 | COMMAND TRIAL |
| 250011021 | 250008213 | null | 87.4 | Palliative (P) | 2019-03-09 | 2019-03-09 | Carboplatin + Etoposide IV 3 day | 2 | Y | 250013836 | GEMCARBO |
| 250011022 | 250008216 | 1.74 | 97 | Curative (C) | 2019-03-29 | 2019-03-29 | CISPLATIN + Ganetespib + Ganetespib + PEMETREXED | 02 | N | 250014072 | IPM |
| 250011023 | 250008217 | 1.7 | 177.2 | Disease modification (D) | 2015-06-08 | 2015-06-08 | Pemetrexed | 02 | N | 250014335 | BENDAMUSTINE + RITUXIMAB |
| 250011024 | 250008219 | 1.8 | 49 | null | 2018-04-07 | 2018-04-15 | Pemetrexed | N | N | 250014676 | IPM |
| 250011025 | 250011067 | 1.77 | 60 | Palliative (P) | 2015-08-22 | 2015-08-22 | Cisplatin + Paclitaxel | N | N | 250015072 | GEMCITABINE |
| 250011026 | 250008220 | 1.83 | 53 | Disease modification (D) | 2018-03-07 | 2018-04-19 | GDP | N | N | 250015208 | GEMCARBO |